NCT07799818

Brief Summary

The aim of the study is to examine patients after knee and hip endoprosthesis in the longitudinal section and to evaluate the surgical outcome.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
34mo left

Started Jul 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Jul 2024Aug 2029

First Submitted

Initial submission to the registry

April 18, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
2.2 years until next milestone

First Posted

Study publicly available on registry

September 2, 2026

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2029

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2029

Last Updated

September 2, 2026

Status Verified

August 1, 2026

Enrollment Period

4.9 years

First QC Date

April 18, 2024

Last Update Submit

August 27, 2026

Conditions

Keywords

Joint prosthesesJoint surgeryKneeHip

Outcome Measures

Primary Outcomes (5)

  • SF 12 Questionnaire

    Health-related quality of life assessed by the SF-12 (score for physical components (PCS) and total score for mental components (MCS) - higher values mean better health, lower values mean worse health with a statistical mean of the total score of 50 (SD 10) (1-100)

    preoperative (approx. 1Day), postoperative (approx. 7 Days), 6-8 weeks postoperative

  • Hand-held dynamometer

    Hand grip force using a hand dynamometer in absolute values (in kg).

    preoperative (approx. 1Day), postoperative (approx. 7 Days), 6-8 weeks postoperative

  • Dual-Energy X-Ray Absorptiometry

    Bone density values by DXA measurement (T- or Z-values as deviation of the measured value from predefined mean values. T-Score ≤ -1 = osteopenia; T-Score ≤ -2,5 = osteoporosis.

    preoperative (approx. 1Day)

  • Dual-Energy X-Ray Absorptiometry

    Body composition in relation to the lean mass. Fat Mass and Lean mass (gram).

    preoperative (approx. 1Day)

  • Dual-Energy X-Ray Absorptiometry

    Fat Mass in percent.

    preoperative (approx. 1Day)

Secondary Outcomes (5)

  • Joint examination (HJHS)

    preoperative (approx. 1Day)

  • Hip examination (Harris Hip Score)

    preoperative (approx. 1Day), postoperative (approx. 7 Days), 6-8 weeks postoperative

  • Knee examination (Knee Society Score)

    preoperative (approx. 1Day), postoperative (approx. 7 Days), 6-8 weeks postoperative

  • Blood samples

    preoperative (approx. 1Day), postoperative (approx. 7 Days), 6-8 weeks postoperative

  • Biomaterial

    during operation

Study Arms (4)

Primary knee prosthesis

Patients who receive a primary knee prosthesis.

Procedure: Joint replacement

Primary hip prosthesis

Patients who receive a primary hip prosthesis.

Procedure: Joint replacement

Revision knee prosthesis

Patients who receive a revision of the knee prosthesis.

Procedure: Joint replacement

Revision hip prosthesis

Patients who receive a revision of the hip prosthesis.

Procedure: Joint replacement

Interventions

Patients routinely receive a joint replacement.

Also known as: Endoprothetics, Arthroplasty
Primary hip prosthesisPrimary knee prosthesisRevision hip prosthesisRevision knee prosthesis

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In this longitudinal study, subjects will be recruited from the patient population of the orthopaedic outpatient clinic of the Clinic and Polyclinic for Orthopaedics and Trauma Surgery at the University Hospital Bonn. A total of 300 patients will be included. This explorative study design is based on the number of cases and the number of operations performed in recent years at the University Hospital Bonn, which amounts to approx. 550 arthroplasty operations per year.

You may qualify if:

  • There is an indication for primary knee or hip replacement or revision.
  • The subject is over 18 years of age.
  • Written consent is given if the subject is fully responsible.

You may not qualify if:

  • A known pregnancy
  • A known mental or pain-associated illness
  • Illness of an airborne infectious disease with an increased risk of mortality and morbidity
  • Patient intolerances or restrictions that make participation in the study impossible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsklinikum Bonn

Bonn, North Rhine-Westphalia, 53127, Germany

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

During the operation, blood, bone, cartilage, synovial fluid, synovial membrane, Hoffa's fat bodies, which are removed during the standard operation, should be preserved.

MeSH Terms

Interventions

Arthroplasty, ReplacementArthroplasty

Intervention Hierarchy (Ancestors)

Orthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Andreas C. Strauss, PD Dr. med.

    University Hospital, Bonn

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andreas C. Strauss, PD Dr. med.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 18, 2024

First Posted

September 2, 2026

Study Start

July 1, 2024

Primary Completion (Estimated)

June 1, 2029

Study Completion (Estimated)

August 1, 2029

Last Updated

September 2, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

The publication of anonymous patient data is not allowed by informed consent.

Locations